BioCalth Receives New Patent
January 31, 2005
1 Min Read
BioCalth Receives New Patent
LA VERNE, Calif.BioCalthInternational Corp. was issued U.S. Patent No. 6,727,288 B2, covering a method of treating bonefractures by administering calcium L-threonate. Studies conducted on theBioCalth dietary supplement found calcium L-threonate could facilitate bonefracture healing and increase bone density and performance. Further information on the BioCalth product is availableonline (www.biocalth.com).
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like